Skip to content
MarketScale
‹ Back to IndustriesHealthcare

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

As most people know, unexpected visits to the doctor can lead to high medical bills. An estimated 1 out of every 5 Americans offset these costs by using a Health Savings Account or HSA to help them save for rainy days or simply to plan ahead. However, it wasn’t long ago that this now…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

As most people know, unexpected visits to the doctor can lead to high medical bills. An estimated 1 out of every 5 Americans offset these costs by using a Health Savings Account or HSA to help them save for rainy days or simply to plan ahead. However, it wasn’t long ago that this now common practice wasn’t possible because of preexisting privacy laws.

On an upcoming episode of I Don’t Care with Kevin Stevenson, Kevin sits down with the Founder and Vice Chairman of Health Equity, Steve Neeleman. Steve was once a doctor and an aspiring entrepreneur who envisioned a concept where you buy insurance for the large events and put the difference in a HSA savings account, which could be used for the “small stuff.”

But, he discovered that when the law establishing HIPPA was passed there was a component that aligned closely with his concept for a health savings account, however, it was limited to a group of small business owners.

With the idea of creating a company called Health Equity, He works between shifts at the hospital on refining and executing the plan, begins lining up investors and takes time off to travel to Washington DC. As a citizen and physician, he lobbies for the passage of legislation for health savings accounts for companies of all sizes.

This is how the idea for his company, Health Equity, was formed. Between shifts at the hospital, he worked to refine his business plan, lining up investors and taking time off to travel to Washington D.C. to lobby for the passage of legislation for health savings accounts for companies of all sizes.

How the COVID-19 Vaccine for Children Differs From Adults’

What is Behind the “Mergers & Acquisitions” Boom in Healthcare?

Should the COVID-19 Vaccine’s Intellectual Property Be Accessible for Everyone?

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512